Related Experiment Video
Updated: Jun 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Sudden cardiac death in adults with congenital heart disease
Sing-Chien Yap1, Louise Harris
1Division of Cardiology, Toronto Congenital Cardiac Centre for Adults, PMCC, University Health Network, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada. s.c.yap@erasmusmc.nl
Insights
Sudden cardiac death (SCD) risk is elevated in adults with congenital heart disease, often due to ventricular arrhythmias. Improving risk prediction is crucial for preventing SCD in this population.
Area of Science:
- Cardiology
- Congenital Heart Disease
- Sudden Cardiac Death
Background:
- Sudden cardiac death (SCD) is a significant concern in adults with congenital heart disease (CHD), particularly after repairs for cyanotic and left heart obstructive lesions.
- While the overall incidence of SCD in CHD patients is low (0.09% annually), it is substantially higher than in age-matched controls.
- Arrhythmia, primarily ventricular arrhythmia, is the most common cause of SCD in this population.
Purpose of the Study:
- To highlight the increased risk of sudden cardiac death (SCD) in patients with congenital heart disease (CHD).
- To discuss the challenges in predicting SCD due to weak risk factors and limited data on interventions like implantable cardioverter-defibrillators (ICDs) and catheter ablation.
- To emphasize the need for improved risk stratification strategies in CHD patients.
Main Methods:
- Review of existing literature on sudden cardiac death (SCD) risk factors in congenital heart disease (CHD).
- Analysis of current data on implantable cardioverter-defibrillators (ICDs) and catheter ablation for ventricular tachycardia (VT) in CHD patients.
- Discussion of limitations in predictive value of known risk factors and absence of randomized trials for interventions.
Main Results:
- Ventricular arrhythmia is the most frequent cause of sudden cardiac death (SCD) in patients with congenital heart disease (CHD).
- Established risk factors have limited predictive value for SCD occurrence.
- Experience with implantable cardioverter-defibrillators (ICDs) is limited to observational studies, and patient selection is challenging.
- Catheter ablation shows promise for arrhythmia burden reduction, but long-term outcomes remain uncertain.
Conclusions:
- Sudden cardiac death (SCD) remains a critical concern for adults with congenital heart disease (CHD), driven by ventricular arrhythmias.
- Current methods for risk stratification and prophylactic interventions like implantable cardioverter-defibrillators (ICDs) are limited by weak predictors and lack of robust clinical trial data.
- Future research must prioritize developing more effective risk stratification tools to improve outcomes for CHD patients at risk of SCD.
Abstract:
Sudden cardiac death is one of the leading causes of death in patients with congenital heart disease, especially in patients with repaired cyanotic and left heart obstructive lesions. While the overall annual incidence of sudden cardiac death is relatively low, estimated at 0.09% per year, this nonetheless represents a many-fold increase over that of comparable age-matched control populations. The most frequent cause of sudden cardiac death is believed to be arrhythmic, usually ventricular arrhythmia. Most studies investigating risk factors for ventricular arrhythmia and/or sudden cardiac death have focused on patients with repaired tetralogy of Fallot and patients with Mustard/Senning repair for complete transposition of the great arteries. Despite a multitude of risk factors, their predictive value for the occurrence of sudden cardiac death is relatively low. Current experience with implantable cardioverter defibrillators in this patient population is limited to observational studies and the selection of patients for prophylactic implantable cardioverter defibrillator implantation is impeded both by the absence of randomized trials and weak predictors. Catheter ablation of ventricular tachycardia has emerged as a promising therapy for abolishing or reducing the burden of arrhythmia but experience is still limited and the impact on long-term outcome uncertain. Future studies will have to focus on improving risk stratification of patients with congenital heart disease.
More Related Videos
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery (ALCAPA)
Published on: April 24, 2017
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy II: Dilated Cardiomyopathy